Profile
BGLC DHR-PB TMO DHR A IDXX
Company Name BioNexus Gene Lab Corp. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation Agilent Technologies, Inc. IDEXX Laboratories, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $5.17M $916.76B $193.04B $151.80B $34.36B $33.70B
Employees 0.03K 79.00K 125.00K 61.00K 17.90K 11.00K
CEO Mr. Su-Leng Tan Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Padraig McDonnell Mr. Jonathan J. Mazelsky
Ratings
BGLC DHR-PB TMO DHR A IDXX
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
BGLC DHR-PB TMO DHR A IDXX
Last Close $0.2346 $1261.26 $437.91 $181.77 $103 $393.73
High 52 $0.85 $1261.26 $624.21 $280.76 $154.64 $548.53
Low 52 $0.23 $1261.26 $437.32 $181.77 $103 $393.73
Price vs. 52 Week High -72.4 % 0 % -29.85 % -35.26 % -33.39 % -28.22 %
Price vs. 52 Week Low 2 % 0 % 0.13 % 0 % 0 % 0 %
Total Return
BGLC DHR-PB TMO DHR A IDXX
1 Month Return -32 % 0 % -17.01 % -15.38 % -18.61 % -8.19 %
3 Month Return -35.01 % 0 % -18.48 % -23.69 % -24.5 % -8.26 %
6 Month Return -44.37 % 0 % -26.85 % -32.69 % -28.95 % -17.57 %
9 Month Return -49.43 % 0 % -18.92 % -24.03 % -18.49 % -18.99 %
YTD Return -16.12 % 0 % -15.82 % -20.81 % -23.33 % -4.77 %
1 Year Return -63.46 % 0 % -24.43 % -25.59 % -28.53 % -24.22 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BGLC DHR-PB TMO DHR A IDXX
Dividend Yield Percentage (TTM) - 0.56 % 0.31 % 0.51 % 0.79 % -
Dividend Paid and Capex Coverage Ration (TTM) -8.22 % 3.1 % 4.37 % 3.1 % 3.01 % 7.1 %
Dividend Per Share (TTM) - 1.13 % 1.6 % 1.08 % 0.96 % -
Payout Ratio (TTM) -7.46 % 19.7 % 9.2 % 19.7 % 21.92 % -
Profitability
BGLC DHR-PB TMO DHR A IDXX
Gross Profit Margin TTM 13.25 % 59.5 % 41.49 % 59.5 % 53.97 % 61.08 %
Return on Assets TTM -8.57 % 5.03 % 6.51 % 5.03 % 10.57 % 26.96 %
Return on Equity TTM -9.94 % 7.64 % 13.24 % 7.64 % 20.95 % 55.82 %
Return on Capital Employed TTM -11.51 % 6.87 % 8.73 % 6.87 % 14.73 % 50.78 %
Net Income Per EBT TTM 102.42 % 83.92 % 90.04 % 83.92 % 84.78 % 80 %
EBT Per Ebit TTM 83.46 % 95.54 % 95.98 % 95.54 % 100.34 % 98.21 %
EBIT Per Revenue TTM -11.91 % 20.37 % 17.1 % 20.37 % 22.65 % 28.99 %
Cash Flow To Debt Ratio TTM -1068.12 % 41.79 % 27.71 % 41.79 % 50.46 % 94.13 %
Receivables Turnover TTM 6.5 6.75 5.23 6.75 4.92 6.94
Payables Turnover TTM 7.78 5.52 - 5.52 5.5 13.28
Inventory Turnover TTM 5.78 4.15 5.04 4.15 3.02 3.97
Fixed Asset Turnover TTM 472.1 % 478.46 % 460.77 % 478.46 % 359.75 % 470 %
Asset Turnover TTM 84.22 % 30.79 % 44.06 % 30.79 % 54.83 % 118.34 %
Operating Cash Flow Per Share TTM -0.13 9.25 22.69 9.18 5.95 11.29
Free Cash Flow Per Share TTM -0.15 7.33 19.02 7.27 4.94 9.7
Cash Per Share TTM 23.03 % 287.53 % 1458.12 % 285.1 % 514.74 % 350.25 %
Operating Cash Flow Sales Ratio TTM -26.14 % 28.01 % 20.21 % 28.01 % 25.98 % 23.84 %
Free Cash Flow Operating Cash Flow Ratio TTM 108.84 % 79.19 % 83.85 % 79.19 % 83.03 % 85.91 %
Cash Flow Coverage Ratios TTM -1068.12 % 41.79 % 27.71 % 41.79 % 50.46 % 94.13 %
Price To Free Cash Flows Ratio TTM -1.96 27.07 26.56 28.66 24.38 42.23
Price To Operating Cash Flows Ratio TTM -2.13 21.65 22.55 23.15 20.24 36.84
Price Cash Flow Ratio TTM -2.13 21.65 22.55 23.15 20.24 36.84
Income Statement (TTM)
BGLC DHR-PB TMO DHR A IDXX
Revenue $0.01B $23.88B $42.88B $23.88B $6.51B $3.9B
Gross Profit $0B $14.21B $18.11B $14.21B $3.54B $2.38B
Gross Profit Ratio 13.61% 59.5% 42.23% 59.5% 54.3% 61.04%
EBITDA $-0B $4.86B $11.54B $4.86B $1.49B $1.27B
Net Income $-0B $3.9B $6.34B $3.9B $1.29B $0.89B
EPS Diluted -0.17 5.29 16.54 5.29 4.43 10.69
Balance Sheet (MRQ)
BGLC DHR-PB TMO DHR A IDXX
Long Term Debt $0B $15.5B $29.06B $15.5B $3.35B $0.55B
Total Liabilities $0B $27.99B $47.65B $27.99B $5.95B $1.7B
Total Equity $0.01B $49.55B $49.67B $49.55B $5.9B $1.6B
Total Investments $0B $0B $1.56B $0B $0.18B $0.06B
Total Debt $0B $16.01B $31.28B $16.01B $3.39B $0.99B
Total Assets $0.01B $77.54B $97.32B $77.54B $11.85B $3.29B
Cash Flow Statement (TTM)
BGLC DHR-PB TMO DHR A IDXX
Net Income $-0B $3.9B $6.34B $3.9B $1.29B $0.89B
Inventory $-0B $0.15B $0B $0.15B $0.03B $-0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $-0.27B $0B
Operating Cash Flow $-0B $6.69B $8.67B $6.69B $1.75B $0.93B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.38B $-0.13B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 103
ACRS Aclaris Therapeutics, Inc. 1.4
ADVB Advanced Biomed Inc. Common Stock 3.36
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 1.45
AWH Aspira Women's Health Inc. 0.094
BDSX Biodesix, Inc. 0.5704
BIAF bioAffinity Technologies, Inc. 0.6834
BIAFW bioAffinity Technologies, Inc. 0.2222
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 3.03
BNR Burning Rock Biotech Limited 3.7724
CDNA CareDx, Inc 17.28
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.6701
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 136.9
CSTL Castle Biosciences, Inc. 18.57
DGX Quest Diagnostics Incorporated 164.18
Unlock